Table 2 Causes of deaths in surgically resected patients (n = 52)

From: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

 

Monotherapy

SBRT + durvalumab

Disease

6

3

COVID

0

2

Respiratory failure/pneumonia

0

1

Unknown cause

0

1

Total

6

7

Back to article page